Correction: miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4 (Cancer Research (2012) 72 (3631–3641) DOI: 10.1158/0008-5472.CAN-12-0667);MiR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4

Cancer Research

Volumn 72, Issue 14, 2012, Pages 3631-3641

  Chen, Hsin Yi ^a   Lin, Yu Min ^a,b   Chung, Hsiang Ching ^a,b   Lang, Yaw Dong ^a   Lin, Ching Jung ^a,b   Huang, John ^c   Wang, Wei Chi ^d   Lin, Feng Mao ^d   Chen, Zhen ^e   Huang, Hsien Da ^d   Shyy, John Y J ^e   Liang, Jin Tung ^c   Chen, Ruey Hwa ^a,b  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; DEATH ASSOCIATED PROTEIN KINASE; KRUPPEL LIKE FACTOR 4; MICRORNA; MICRORNA 103; MICRORNA 107; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CELL ADHESION; CELL HYPOXIA; CELL MOTILITY; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE MODEL; DISTANT METASTASIS; DOWN REGULATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING;

EID: 84863891322     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-17-3079     Document Type: Erratum

References (43)

1. Fidler IJ, Yano S, Zhang RD, Fujimaki T, Bucana CD. The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 2002;3:53-7. (Pubitemid 34121146)
2. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274-84.
3. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904. (Pubitemid 44175140)
4. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, et al. DAP kinase links the control of apoptosis to metastasis. Nature 1997;390:180-4. (Pubitemid 27507988)
5. Wang WJ, Kuo JC, Yao CC, Chen RH. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 2002;159:169-79.
6. Kuo JC, Wang WJ, Yao CC, Wu PR, Chen RH. The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway. J Cell Biol 2006;172:619-31.
7. Gozuacik D, Kimchi A. DAPk protein family and cancer. Autophagy 2006;2:74-9.
8. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 1996;271:20009-17.
9. Ghaleb AM, McConnell BB, Kaestner KH, Yang VW. Altered intestinal epithelial homeostasis in mice with intestine-specific deletion of the Kruppel-like factor 4 gene. Dev Biol 2011;349:310-20.
10. Choi BJ, Cho YG, Song JW, Kim CJ, Kim SY, Nam SW, et al. Altered expression of the KLF4 in colorectal cancers. Pathol Res Pract 2006;202:585-9.
11. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005;65:2746-54. (Pubitemid 40490076)
12. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW, et al. Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004;23:395-402. (Pubitemid 38174993)
13. Patel NV, Ghaleb AM, Nandan MO, Yang VW. Expression of the tumor suppressor Kruppel-like factor 4 as a prognostic predictor for colon cancer. Cancer Epidemiol Biomarkers Prev 2010;19:2631-8.
14. Ghaleb AM, McConnell BB, Nandan MO, Katz JP, Kaestner KH, Yang VW, et al. Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res 2007;67:7147-54. (Pubitemid 47206542)
15. Dang DT, Chen X, Feng J, Torbenson M, Dang LH, Yang VW, et al. Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene 2003;22:3424-30. (Pubitemid 36713740)
16. Li R, Liang J, Ni S, Zhou T, Qing X, Li H, et al. A mesenchymal-to- epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010;7:51-63.
17. Yori JL, Johnson E, Zhou G, Jain MK, Keri RA. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 2010;285:16854-63.
18. Wei D, Kanai M, Jia Z, Le X, Xie K. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 2008;68:4631-9.
19. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
20. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31. (Pubitemid 38868508)
21. Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl) 2011;89:445-57.
22. White NM, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM, et al. Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol 2011;8:75-84.
23. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, et al. A MicroRNA targeting dicer for metastasis control. Cell 2010;141:1195-207.
24. Faber C, Horst D, Hlubek F, Kirchner T. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 2011;47:1414-9.
25. Papachristou DJ, Korpetinou A, Giannopoulou E, Antonacopoulou AG, Papadaki H, Grivas P, et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch 2011;459:431-40.
26. Bhullar JS, Subhas G, Silberberg B, Tilak J, Andrus L, Decker M, et al. A novel nonoperative orthotopic colorectal cancer murine model using electrocoagulation. J Am Coll Surg 2011;213:54-60; discussion 60-1.
27. Kuo TH, Kubota T, Watanabe M, Furukawa T, Teramoto T, Ishibiki K, et al. Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci U S A 1995;92:12085-9. (Pubitemid 26014016)
28. Opolski A, Wietrzyk J, Duś D, Kieda C, Matejuk A, Makowska A, et al. Metastatic potential and saccharide antigens expression of human colon cancer cells xenotransplanted into athymic nude mice. Folia Microbiol (Praha) 1998;43:507-10. (Pubitemid 128439393)
29. Rajput A, Dominguez San Martin I, Rose R, Beko A, Levea C, Sharratt E, et al. Characterization of HCT116 human colon cancer cells in an orthotopic model. J Surg Res 2008;147:276-81. (Pubitemid 351680466)
30. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 1994;54:4805-12. (Pubitemid 24276516)
31. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS, et al. Human MicroRNA targets. PLoS Biol 2004;2:e363.
32. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP, et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007;27:91-105. (Pubitemid 46991392)
33. Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle 2008;7:2991-6.
34. Finger EC, Giaccia AJ. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 2010;29:285-93.
35. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, et al. A microRNA signature of hypoxia. Mol Cell Biol 2007;27:1859-67.
36. Ebert MP, Mooney SH, Tonnes-Priddy L, Lograsso J, Hoffmann J, Chen J, et al. Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers. Neoplasia 2005;7:771-8.
37. Schneider-Stock R, Kuester D, Ullrich O, Mittag F, Habold C, Boltze C, et al. Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cells. J Pathol 2006;209:95-105.
38. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter Cp Gislands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 2004;10:3441-54.
39. Wang WJ, Kuo JC, Ku W, Lee YR, Lin FC, Chang YL, et al. The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR. Mol Cell 2007;27:701-16. (Pubitemid 47333224)
40. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 2010;285:7986-94.
41. Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer 2006;6:11-23. (Pubitemid 43053649)
42. Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, et al. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 2011;10:99.
43. Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, et al. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 2011;121:3442-55.